PL BIOSCIENCE
STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
PL BIOSCIENCE
Social Links:
Industry:
Biotechnology Health Care
Founded:
2015-01-01
Address:
Aachen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.pl-bioscience.com
Total Employee:
1+
Status:
Active
Contact:
+49 241 95719-100
Email Addresses:
[email protected]
Total Funding:
3.7 M EUR
Technology used in webpage:
CrUX Dataset Pound Sterling CrUX Top 10m All-Inkl
Similar Organizations
Austen BioInnovation Institute
Advance Value-Added, Patient-Centered Healthcare Solutions .
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
Roche Diagnostics
Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.
Current Advisors List
Founder
Investors List
TechVision Fund
TechVision Fund investment in Seed Round - PL BioScience
Official Site Inspections
http://www.pl-bioscience.com Semrush global rank: 7.27 M Semrush visits lastest month: 830
- Host name: dd28830.kasserver.com
- IP address: 85.13.149.77
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "PL BioScience"
PL BioScience
Since PL BioScience is growing and we are emerging from the early business stages, it’s time for a change. We think our patented Human Platelet Lysate technology deserves a suitable and …See details»
The management team from PL BioScience
PL BioScience was founded in 2015 as a spin-off of the RWTH Aachen University. But our story goes back to 2013, when our CEO, Dr. Hatim Hemeda, worked in stem cell research: He achieved best results with an own-produced …See details»
PL BioScience - Crunchbase Company Profile & Funding
PL BioScience closed its last funding round on Aug 8, 2024 from a Series A round. Who are PL BioScience 's competitors? Alternatives and possible …See details»
PL BioScience GmbH - LinkedIn
PL BioScience GmbH Biotechnology Aachen, North Rhine-Westphalia 3,639 followers Changing cell culture with animal-free cell growth promotersSee details»
PL BioScience GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for PL BioScience GmbH of Aachen, Nordrhein-Westfalen. Get the latest business insights from Dun & Bradstreet.See details»
PL BioScience GmbH. (08.08.2024). „Press Release: PL BioScience …
PL BioScience specializes in manufacturing human growth media for cell cultivation, which are increasingly required for cell therapy development in regenerative medicine. Founded in 2015 …See details»
PL BioScience - VentureRadar
Since PL BioScience is growing and we are emerging from the early business stages, it’s time for a change. We think our patented Human Platelet Lysate technology deserves a suitable and …See details»
PL BioScience GmbH - Aachen, Germany - bionity.com
We at PL BioScience are experts in cell culture supplements derived from human Platelets. Our mission is to enhance the advances in cellular research and therapy with one forward-looking …See details»
PL BioScience Clinisciences
PL BioScience is a dynamic biotechnology startup based in Aachen, Germany, with an extensive network of international clients and partners. Driven by a shared passion for science and …See details»
PL BioScience - Krishgen Biosystems
PL BioScience GmbH is a Germany-based life science company committed to delivering safe and animal component-free cell expansion tools. PL BioScience was founded in 2015 as an RWTH …See details»
PL Bioscience - Products, Competitors, Financials, Employees ...
PL Bioscience specializes in the development of cell culture supplements derived from human platelet lysate, catering to the regenerative medicine sector. The company offers a range of …See details»
PL BioScience - PitchBook
PL BioScience General Information Description. Developer of animal-free cell culture services designed to bridge the gap between research and clinical applications. The company's …See details»
Press Release Distribution and Management - GlobeNewswire
Apr 30, 2025 PL BioScience Launches World’s Only Patented Gamma-irradiated Human Platelet Lysate. New high-quality cell growth supplement for cell manufacturing applications …See details»
PL BioScience closes € 7.8 million Series A Financing
PL BioScience secures position as provider of growth-promoting cell culture media advancing therapeutic developments in regenerative medicine. AACHEN, Germany, 8th August 2024 – …See details»
Why AVANT BIO Invested: PL BioScience
Nov 11, 2024 PL BioScience, an Innovator in Cell Culture. PL BioScience GmbH (“PL BioScience”) specializes in the production and development of human platelet lysate (HPL), a …See details»
Captivate Bio signs distribution agreement with PL BioScience
Based in Germany, PL BioScience launched several products based on the potential of human platelets – the basis of its growth-promoting cell culture media. ELAREM™ is a family of …See details»
PL BioScience Raises the Bar in Cell Culture Technology
5 days ago About PL BioScience: PL BioScience GmbH, a life science company located in Aachen, Germany, specializes in the production and development of Human Platelet Lysate …See details»
PL BioScience Raises the Bar in Cell Culture Technology with First ...
5 days ago PL BioScience currently offers a comprehensive portfolio of donor-derived, natural HPL products tailored for a range of applications. From academic and preclinical research to …See details»
Captivate Bio signs exclusive agreement with PL BioScience
Jun 28, 2021 Captivate Bio will supply all ELAREM™ human platelet lysate product lines for sale in the US and Canada. June 28, 2021. Captivate Bio, a scientific cell culture solutions …See details»
Press Releases Archives - PL BioScience
Apr 8, 2019 PL BioScience raises € 3.7 mln investment. PL BioScience raises € 3.7 mln from Born2Grow, Brightlands Venture Partners, TechVision Fund I and more The capital will be …See details»